Efficacy and Safety From a Phase 2B Trial of SM04690, a Novel, Intra-Articular, WNT Pathway Inhibitor for the Treatment of Osteoarthritis of the Knee
Osteoarthritis and Cartilage - United Kingdom
doi 10.1016/j.joca.2019.02.566
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2019
Authors
Publisher
Elsevier BV